Reva Medical, Inc

( ASX:RVA ) - Health Care Equipment & Services

Analyst Views

RVA – CIMB rates the stock as Outperform

Reva is restructuring to focus exclusively on early stage, bioresorbable ‘Fantom’ scaffolds in lieu of further development of ReZolve2, which was to be commercialised next year. CIMB thinks Fantom scaffolds underpin the competitive advantage for the company and offer other advantages.

Read More